Oxygen and Aerosol Delivery Devices Market Gains Traction in Asia Pacific Amid Rising Healthcare Infrastructure and Expanding Patient Pool

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Oxygen and Aerosol Delivery Devices Market- by Product (Oxygen Masks, Nasal Cannulas/ Oxygen catheters, Oxygen Connecting Tube, Venturi Masks, Non-rebreather Masks, Reusable Nebuliser, Disposable Nebuliser and Other Oxygen Delivery Devices), Application (COPD, Asthma, Cystic Fibrosis, Respiratory Distress Syndrome, Pneumonia and Other Diseases), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the global oxygen and aerosol delivery devices market is valued at 43.14 Billion in 2023, and it is expected to reach 74.64 Billion by the year 2031 with a CAGR of 7.3 % during a forecast period of 20224-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1275

Oxygen and aerosol delivery systems play a critical role in the treatment of both respiratory and non-respiratory conditions, functioning as either emergency interventions or components of long-term therapeutic regimens. The most advanced drug delivery methods involve direct administration to the lungs, enabling systemic therapeutic effects. Commonly used devices in this category include dry powder inhalers (DPIs), metered-dose inhalers (MDIs), and nebulizers, which are extensively utilized in the management of chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Beyond respiratory disorders, these delivery systems are also applied in the treatment of conditions like diabetes, Parkinson's disease, and pain management.

The global market for oxygen and aerosol delivery devices is primarily driven by the rising prevalence of respiratory diseases-including asthma and COPD-an increase in smoking rates, growing demand for MDIs, and technological advancements that simplify medication administration through aerosol-based systems. Furthermore, the expanding number of research and development initiatives aimed at optimizing inhalation therapies is expected to further contribute to market growth. However, potential limitations include the side effects associated with inhaled medications and the high cost of nebulizer devices, both of which may pose challenges to widespread adoption.

North America is expected to dominate the global oxygen and aerosol delivery devices market throughout the forecast period, supported by a large population affected by asthma and COPD, favorable healthcare reforms, increased awareness of inhalation therapies, strong accessibility to advanced medical devices, and robust R&D activity. In parallel, the Asia-Pacific region is projected to experience substantial growth, driven by rising demand for home healthcare solutions, increased adoption of inhalers and nebulizers, and improving healthcare infrastructure. Key industry players are increasingly focusing on expanding their geographic footprint in emerging Asia-Pacific markets to capture a larger share of the growing demand for oxygen and aerosol delivery devices.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Major market players operating in the Oxygen and Aerosol Delivery Devices market include
Medline Industries, Inc., Salter Labs Inc., Vygon SA, Smiths Medical, Inc., Medicoplast International GmbH, Purple Surgical, Pennine Healthcare, Besmed Health Business Corp., Intersurgical Ltd, B. Braun Melsungen AG, ConvaTec Inc., Flexicare Medical Ltd., GaleMed Corporation, PARI GmbH, Polymedicure, Teleflex Incorporated, HSINER CO., LTD., ASID BONZ GmbH and Sumi spółka z ograniczoną.

Recent collaborations and agreements in the market:
• In December 2021, Positive results from the second randomized, placebo-controlled Phase-2 research comparing PUL-042 to COVID-19 were reported by Pulmotect. Patients treated with inhaled PUL-042 had excellent efficacy signals for COVID-19 prevention and therapy, reduced respiratory symptoms, and reduced critical care unit hospitalizations, in addition to probable effectiveness against all SARS-CoV-2 variants.
• In June 2021, a significant portion of Teleflex Incorporated's Respiratory division was recently sold to Medline Industries, Inc. (referred to as "Medline"), as previously stated. Among the Teleflex respiratory product lines purchased are Hudson RCI® devices for oxygen and aerosol treatment, active humidification, non-invasive ventilation, and incentive spirometers, with a projected total sale of $139 million in 2020.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1275

Market Segments
Global Oxygen and Aerosol Delivery Devices Market, by Product, 2022-2030 (Value US$ Mn)
• Oxygen Masks
• Nasal Cannulas/ Oxygen Catheter
• Oxygen Connecting Tube
• Venturi Masks
• Non-rebreather Masks
• Reusable Nebulizer
• Disposable Nebulizer
• Other Oxygen Delivery Devices
Global Oxygen and Aerosol Delivery Devices Market, by Application, 2022-2030 (Value US$ Mn)
• COPD
• Asthma
• Cystic Fibrosis
• Respiratory Distress Syndrome
• Pneumonia
• Other Diseases
Global Oxygen and Aerosol Delivery Devices Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Oxygen and Aerosol Delivery Devices Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Oxygen and Aerosol Delivery Devices Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Oxygen and Aerosol Delivery Devices Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Oxygen and Aerosol Delivery Devices Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Oxygen and Aerosol Delivery Devices Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global oxygen and aerosol delivery devices market
 To receive an industry overview and future trends of the oxygen and aerosol delivery devices market
 To analyze the oxygen and aerosol delivery devices market drivers and challenges
 To get information on the oxygen and aerosol delivery devices market value (US$Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the oxygen and aerosol delivery devices market industry

Read Overview Report- https://www.insightaceanalytic.com/report/global-oxygen-and-aerosol-delivery-devices-market-/1275

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.